Results 11 to 20 of about 20,467 (239)

Macular oedema as manifestation of diabetic retinopathy

Сахарный диабет, 2017
Diabetes mellitus is the third most dangerous disease of our time preceded by cardiovascular diseases and oncologic pathology. According to the International Diabetes Federation (January 1, 2016), worldwide approximately 415 million people aged 20&ndash ...
Mukharram M. Bikbov, Rinat R. Fayzrakhmanov, Rinat M. Zaynullin, Artur F. Zaynetdinov, Timur R. Gilmanshin, Marat R. Kalanov   +5 more
doaj   +3 more sources

Indicators of Visual Prognosis in Diabetic Macular Oedema [PDF]

Journal of Personalized Medicine, 2021
Diabetic macular oedema (DMO) is an important cause of moderate vision loss in people with diabetes. Advances in imaging technology have shown that a significant proportion of patients with DMO respond sub-optimally to existing treatment options. Identifying associations and predictors of response before treatment is initiated may help in explaining ...
Sagnik Sen, Kim Ramasamy, Sobha Sivaprasad   +2 more
openaire   +2 more sources

Intravitreal Bevacizumab Alone Versus Combined Bevacizumab and Macular Grid Laser Photocoagulation in Diffuse Diabetic Macular Oedema [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Diabetes Mellitus (DM) is a common disease with multiple systemic complications. Diabetic macular oedema is the main threat to vision in patients with diabetic retinopathy, which results from the increased permeability of the inner and ...
Fawaz Al Sarireh, Hamzeh Mohammad Alrawashdeh, Khalid Al Zubi, Khalil Al Salem   +3 more
doaj   +1 more source

Diabetic vitreopapillary traction and macular oedema [PDF]

Eye, 2004
To describe an association between optic disc traction and diabetic macular oedema (DME) unresponsive to laser treatment.A retrospective review of all patients with DME who attended our clinic between September 2001 and November 2003 was undertaken.
M, Karatas, J A, Ramirez, A, Ophir
openaire   +2 more sources

Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study

Health Technology Assessment, 2021
Background: Owing to the increasing prevalence of diabetes, the workload related to diabetic macular oedema and proliferative diabetic retinopathy is rising, making it difficult for hospital eye services to meet demands.
Noemi Lois, Jonathan Cook, Ariel Wang, Stephen Aldington, Hema Mistry, Mandy Maredza, Danny McAuley, Tariq Aslam, Clare Bailey, Victor Chong, Faruque Ghanchi, Peter Scanlon, Sobha Sivaprasad, David Steel, Caroline Styles, Augusto Azuara-Blanco, Lindsay Prior, Norman Waugh   +17 more
doaj   +1 more source

Changing Perspectives in Diabetic Macular Oedema – Recognising and Understanding Chronic Diabetic Macular Oedema [PDF]

European Ophthalmic Review, 2014
The satellite symposium moderated by Usha Chakravarthy entitled ‘Changing Perspectives in Diabetic Macular Oedema: Recognising and Understanding Chronic Diabetic Macular Oedema’ was convened at the 2014 EURETINA Congress. The symposium discussed the multiple processes involved in chronic diabetic macular oedema (DMO) and the use of medications, in ...
Pascale Massin, Michael Diestelhorst, Yit Yang, Albert Augustin, Usha Chakravarthy   +4 more
openaire   +1 more source

External validation of cut-off points for foveal thickness taking into account the intraretinal fluid using optical coherence tomography to diagnose diabetic macular oedema [PDF]

PeerJ, 2017
Background In late 2015, cut-off points were published for foveal thickness to diagnose diabetic macular oedema taking into account the presence of intraretinal fluid using optical coherence tomography (OCT) in primary care patients (90 µm in the ...
Carmen Hernández-Martínez, Antonio Palazón-Bru, Cesar Azrak, Aída Navarro-Navarro, Manuel Vicente Baeza-Díaz, José Juan Martínez-Toldos, Vicente Francisco Gil-Guillén   +6 more
doaj   +2 more sources

Variability in photocoagulation treatment of diabetic macular oedema [PDF]

Acta Ophthalmologica, 2012
To establish whether differences in the assessment of diabetic macular oedema (DME) with either optical coherence tomography (OCT) or stereoscopic biomicroscopy lead to variability in the photocoagulation treatment of DME.The differences in the assessment of DME with either OCT or stereoscopic biomicroscopy were analysed by calculating the surface ...
van Dijk, Hille W., Verbraak, Frank D., Kok, Pauline H. B., Oberstein, Sarit Y. L., Schlingemann, Reinier O., Russell, Stephen R., Abràmoff, Michael D.   +6 more
openaire   +3 more sources

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema [PDF]

Farmacia Hospitalaria, 2018
: Objective: To assess the economic impact following the inclusion of an intravitreal implant of dexamethasone for the treatment of diabetic macular oedema in a healthcare area in Spain.
Fernando de Andrés-Nogales , Enrique Cervera , Félix Armadá , Luis Arias , Itziar Oyagüez , Concha Martínez   +5 more
doaj   +1 more source

Relationship of diabetic macular oedema with glycosylated haemoglobin [PDF]

Eye, 2008
To evaluate the correlation between glycosylated haemoglobin (HbA1c) and central foveal thickness as measured by optical coherence tomography (OCT) in patients with diabetes.Retrospectively review of medical records of central foveal thickness as measured by OCT and laboratory data of glycosylated haemoglobin.
T-H, Chou, P-C, Wu, J Z-C, Kuo, C-H, Lai, C-N, Kuo   +4 more
openaire   +2 more sources